Skip to main content
Earnings Labs
Outlook Therapeutics, Inc. logo

Outlook Therapeutics, Inc. (OTLK)

NASDAQ·Healthcare·Biotechnology

$0.44

+0.60%

Mkt Cap $112.50M

Analyst Ratings

Buy

4

Hold

2

Sell

0

Price Target (4 analysts)

$2.80

Range $1.60 – $4.00

Implied Upside

+541.6%

Consensus $2.80 vs current $0.44